United Therapeutics Return on Tangible Equity 2012-2026 | UTHR

Current and historical return on tangible equity values for United Therapeutics (UTHR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
United Therapeutics Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-12-31 $1.34B $6.80B 19.62%
2025-09-30 $1.27B $6.64B 19.15%
2025-06-30 $1.24B $6.52B 19.05%
2025-03-31 $1.21B $6.15B 19.68%
2024-12-31 $1.20B $5.78B 20.67%
2024-09-30 $1.11B $5.67B 19.61%
2024-06-30 $1.07B $5.59B 19.16%
2024-03-31 $1.05B $5.53B 19.00%
2023-12-31 $0.99B $5.50B 17.92%
2023-09-30 $0.90B $5.22B 17.25%
2023-06-30 $0.87B $4.93B 17.67%
2023-03-31 $0.73B $4.66B 15.64%
2022-12-31 $0.73B $4.42B 16.45%
2022-09-30 $0.71B $4.21B 16.80%
2022-06-30 $0.63B $4.03B 15.67%
2022-03-31 $0.69B $3.86B 17.84%
2021-12-31 $0.48B $3.67B 12.96%
2021-09-30 $0.46B $3.51B 13.21%
2021-06-30 $0.47B $3.34B 14.10%
2021-03-31 $0.41B $3.18B 12.76%
2020-12-31 $0.52B $3.02B 17.04%
2020-09-30 $0.47B $2.87B 16.35%
2020-06-30 $0.43B $2.73B 15.77%
2020-03-31 $0.53B $2.59B 20.37%
2019-12-31 $-0.11B $2.43B -4.32%
2019-09-30 $-0.09B $2.43B -3.83%
2019-06-30 $-0.12B $2.42B -4.87%
2019-03-31 $-0.15B $2.45B -6.12%
2018-12-31 $0.59B $2.50B 23.63%
2018-09-30 $0.54B $2.36B 23.09%
2018-06-30 $0.71B $2.23B 31.96%
2018-03-31 $0.48B $2.03B 23.80%
2017-12-31 $0.42B $1.96B 21.32%
2017-09-30 $0.51B $1.90B 26.78%
2017-06-30 $0.40B $1.85B 21.39%
2017-03-31 $0.66B $1.86B 35.38%
2016-12-31 $0.71B $1.77B 40.38%
2016-09-30 $0.71B $1.70B 41.61%
2016-06-30 $1.01B $1.61B 62.72%
2016-03-31 $0.90B $1.42B 63.57%
2015-12-31 $0.65B $1.27B 51.34%
2015-09-30 $0.66B $1.18B 56.04%
2015-06-30 $0.17B $1.11B 15.54%
2015-03-31 $0.19B $1.15B 16.17%
2014-12-31 $0.34B $1.21B 28.18%
2014-09-30 $0.20B $1.22B 16.01%
2014-06-30 $0.28B $1.24B 22.86%
2014-03-31 $0.25B $1.24B 20.31%
2013-12-31 $0.18B $1.19B 14.66%
2013-09-30 $0.29B $1.15B 25.05%
2013-06-30 $0.30B $1.10B 27.56%
2013-03-31 $0.30B $1.06B 27.83%
2012-12-31 $0.30B $1.03B 29.62%
2012-09-30 $0.26B $0.99B 26.65%
2012-06-30 $0.27B $1.00B 27.10%
2012-03-31 $0.27B $1.00B 27.30%
2011-12-31 $0.22B $0.98B 22.26%
2011-09-30 $0.18B $0.96B 19.13%
2011-06-30 $0.14B $0.90B 15.53%
2011-03-31 $0.10B $0.85B 12.31%
2010-12-31 $0.11B $0.79B 13.48%
2010-09-30 $0.09B $0.73B 12.81%
2010-06-30 $0.07B $0.68B 9.66%
2010-03-31 $0.03B $0.64B 4.06%
2009-12-31 $0.02B $0.61B 3.30%
2009-09-30 $-0.06B $0.58B -10.12%
2009-06-30 $-0.06B $0.53B -11.30%
2009-03-31 $-0.05B $0.47B -9.78%
2008-12-31 $-0.05B $0.41B -12.02%
2008-09-30 $0.03B $0.34B 7.88%
2008-06-30 $0.03B $0.29B 10.67%
2008-03-31 $0.03B $0.24B 10.25%
2007-12-31 $0.01B $0.20B 6.01%
2007-09-30 $0.07B $0.18B 41.93%
2007-06-30 $0.07B $0.19B 34.90%
2007-03-31 $0.07B $0.22B 31.08%
2006-12-31 $0.07B $0.26B 28.99%
2006-09-30 $0.05B $0.27B 17.26%
2006-06-30 $0.06B $0.26B 20.95%
2006-03-31 $0.06B $0.24B 24.46%
2005-12-31 $0.07B $0.22B 29.51%
2005-09-30 $0.04B $0.20B 21.58%
2005-06-30 $0.03B $0.19B 17.89%
2005-03-31 $0.03B $0.17B 14.47%
2004-12-31 $0.02B $0.16B 9.20%
2004-09-30 $0.01B $0.16B 3.18%
2004-06-30 $0.00B $0.15B -1.30%
2004-03-31 $-0.01B $0.15B -5.20%
2003-12-31 $-0.01B $0.16B -5.83%
2003-09-30 $-0.01B $0.16B -5.80%
2003-06-30 $-0.02B $0.16B -12.80%
2003-03-31 $-0.02B $0.16B -13.10%
2002-12-31 $-0.02B $0.17B -14.48%
2002-09-30 $-0.03B $0.17B -16.30%
2002-06-30 $-0.03B $0.18B -14.55%
2002-03-31 $-0.03B $0.19B -18.35%
2001-12-31 $-0.04B $0.19B -19.15%
2001-09-30 $-0.06B $0.20B -30.66%
2001-06-30 $-0.06B $0.22B -27.35%
2001-03-31 $-0.08B $0.20B -39.54%
2000-12-31 $-0.08B $0.17B -43.93%
2000-09-30 $-0.05B $0.13B -40.30%
2000-06-30 $-0.05B $0.09B -60.47%
2000-03-31 $-0.03B $0.07B -40.14%
1999-12-31 $-0.03B $0.04B -78.57%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $25.058B $3.183B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
USANA Health Sciences (USNA) United States $0.334B 9.43
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00